Litera has acquired AxxiTRIALS, a Clinical Trials Portal solution providing life science companies and CROs with a platform designed to speed site startup, patient recruitment and end-to-end clinical trial operations.

AxxiTRIALS improves operating efficiencies by uniting global trial teams, from Sponsor, CRO and sites, under a single interface that is easy to use, engaging and integrated with existing systems. AxxiTRIALS' customizable workflow tools and compliant document management system speeds the site startup process, ensures compliance, centralizes key trial information, creates community and keeps investigators and site coordinators engaged throughout the clinical trial.

"Pharmaceutical, medical device, biotech and CROs that leverage the power of the web see a tremendous acceleration of trials, particularly in the areas of startup and patient recruitment, enabling life-saving products to get to market faster," said Susan MH Lewenz, founder of AxxiTRIALS and now vice president and general manager at Litera for the AxxiTRIALS franchise. “Interestingly, the CRO clients who have private-labeled the offering tell us that it has even helped them win new business, as many trial sponsors have now witnessed this speed improvement and demand a portal be used for their projects.”

AxxiTRIALS is used for trials of all sizes in locations all around the world to accelerate document handling from feasibility and site start-up documentation, to ongoing safety alert, training and communications management, through the locking of the trial master file.

AxxiTRIALS joins a suite offered by Litera, including its Galaxy portal solution for document and matter collaboration across enterprises, as well as solutions for document templates and numbering, content assembly, document comparison, rights management, large/secure file transfer and synchronization and metadata management.